Friday, Jun 25, 2021
Focus on the big picture

Breakingviews TV: Biogen’s drug

Reuters, 09 Jun 2021
Biogen’s newly approved drug for Alzheimer’s disease could be the biggest seller ever, but it also might not work. Robert Cyran explains this duality and what it says about the U.S. healthcare spending spiral.

#Alzheimer #Biogen #FDA #News #Reuters


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
Related Articles